Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|17|2917-2925

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.17, 2015-09, pp. : 2917-2925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 345-352

Karger

Access to resources Recommend Favorite

Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 50-55

Karger

Access to resources Recommend Favorite

Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 281-290

Karger

Access to resources Recommend Favorite

Treatment of Advanced Hepatocellular Carcinoma: Intraarterial Infusion Chemotherapy Combined with Interferon

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 142-147

Karger

Access to resources Recommend Favorite